Connection
David Ivy to Pyridazines
This is a "connection" page, showing publications David Ivy has written about Pyridazines.
|
|
Connection Strength |
|
|
|
|
|
0.592 |
|
|
|
-
Takatsuki S, Rosenzweig EB, Zuckerman W, Brady D, Calderbank M, Ivy DD. Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension. Pediatr Pulmonol. 2013 Jan; 48(1):27-34.
Score: 0.397
-
Issapour A, Frank B, Crook S, Hite MD, Dorn ML, Rosenzweig EB, Ivy DD, Krishnan US. Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. Pediatr Pulmonol. 2022 03; 57(3):724-733.
Score: 0.195